[Federal Register Volume 83, Number 10 (Tuesday, January 16, 2018)]
[Notices]
[Pages 2215-2216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00506]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before March 19, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 10, 2017, Johnson Matthey Inc., Pharmaceuticals Materials, 900
River Road, Conshohocken, Pennsylvania 19428 applied to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Amphetamine............................ 1100 II
Methylphenidate........................ 1724 II
Codeine................................ 9050 II
Oxycodone.............................. 9143 II
Diphenoxylate.......................... 9170 II
Hydrocodone............................ 9193 II
Meperidine............................. 9230 II
Methadone.............................. 9250 II
Methadone intermediate................. 9254 II
Morphine............................... 9300 II
Thebaine............................... 9333 II
Opium tincture......................... 9630 II
------------------------------------------------------------------------
[[Page 2216]]
The company plans to manufacture the listed controlled substances
in bulk for either internal use or for sale to its customers. Thebaine
(9333) will be used to manufacture other controlled substances for sale
in bulk to its customers.
Dated: January 4, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-00506 Filed 1-12-18; 8:45 am]
BILLING CODE 4410-09-P